Subvalvular Aortic Stenosis: Learning From Human and Canine Clinical Research

Area of Science:

• Cardiology
• Comparative Medicine
• Genetics

Background:

• Subvalvular aortic stenosis (SAS) is a common congenital heart disease in dogs and children.
• A fibrous ridge below the aortic valve obstructs left ventricular outflow, increasing blood flow velocity.
• Canine SAS serves as a valuable translational model for human SAS due to shared pathophysiology and genetics.

Purpose of the Study:

• To highlight the significance of canine subvalvular aortic stenosis as a translational model for human disease.
• To compare current treatment standards for SAS outcomes in veterinary and human medicine.
• To emphasize the need for research into treatments that prevent disease progression or eliminate the obstructive ridge.

Main Methods:

• Comparative analysis of clinical presentation, anatomy, and pathophysiology between canine and human SAS.
• Review of current treatment strategies for SAS-related adverse outcomes in both species.
• Examination of genetic and environmental factors contributing to SAS.

Main Results:

• Canine and human SAS share significant similarities in disease presentation, cardiac development, and genetics.
• Veterinary medicine primarily uses pharmacological interventions, while human medicine favors surgical approaches for SAS outcomes.
• No current treatment effectively prevents SAS progression or removes the obstructive ridge in either species.

Conclusions:

• The translational approach, leveraging canine SAS models, holds the most promise for advancing human SAS research.
• Further research is needed to develop novel therapies for subvalvular aortic stenosis.
• Understanding species-specific treatment differences can inform future therapeutic strategies for SAS.